|
COPYRIGHT 2005 Financial Times Ltd.
(From Japan Corporate News Network)
Byline: Dale Hug-Staff Writer, newsroom@japancorp.net
Bristrol-Myers Squibb (BMS) and Otsuka Pharmaceutical have jointly announced that the US Food and Drug Administration (FDA) approved an additional indication for ABILIFY (aripiprazole) Tablets and Oral Solution, atypical antipsychotics, as of March 1.
With this approval, ABILIFY is...
Read the full article for free courtesy of your local library.
|